Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
PDS Biotechnology Corporation (PDSB) had Weighted-Average Shares Outstanding (Diluted) of 40.52M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-8.49M |
|
-- |
|
-- |
|
$9.11M |
|
$-9.11M |
|
$-0.55M |
|
$-9.66M |
|
$-9.66M |
|
$-8.49M |
|
$-8.49M |
|
$-8.49M |
|
$-8.49M |
|
$-9.11M |
|
$-8.82M |
|
40.52M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
40.52M |
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$42.47M |
|
$0.14M |
|
$4.56M |
|
$47.03M |
|
$18.27M |
|
$6.40M |
|
$6.40M |
|
$24.67M |
|
$22.36M |
|
$22.36M |
|
$22.36M |
|
45.45M |
|
| Cash Flow Statement Financials | |
$-9.03M |
|
-- |
|
$7.32M |
|
$41.69M |
|
$39.98M |
|
$-1.71M |
|
$1.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.33 |
|
-- |
|
-- |
|
0.22 |
|
0.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.96% |
|
-37.96% |
|
-18.05% |
|
-29.51% |
|
$0.49 |
|
$-0.22 |
|
$-0.22 |
|